Metropolis Healthcare Ltd.
NSE: METROPOLIS | BSE: 542650
₹507.40
₹-21.45
(-4.06%)
As on 18-May-2026IST
Market cap
₹10,527 Cr
Revenue (TTM)
₹1,646 Cr
P/E Ratio
55.4
P/B Ratio
7
Div. Yield
0.2 %
Quality Score
9/10
Growth Score
5/10
Valuation Score
4/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹190 Cr
-
ROE
12.1 %
-
ROCE
17.6 %
-
Industry P/E
54.67
-
EV/EBITDA
24.6
-
Debt to Equity
0
-
Book Value
₹73
-
EPS
₹30.6
-
Face value
2
-
Shares outstanding
207,331,968
10 Years Aggregate
CFO
₹1,844.38 Cr
EBITDA
₹2,431.94 Cr
Net Profit
₹1,367.59 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Metropolis Health
| 5.2 | 7.6 | 5.2 | 23.1 | 16.1 | -2.5 | -- |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Metropolis Health
| -6.2 | 24.0 | 26.4 | -61.4 | 70.8 | 36.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Metropolis Health
|
507.4 | 10,527.3 | 1,645.9 | 191.2 | 16.2 | 13.3 | 55.4 | 7.0 |
| 755.3 | 39,123.3 | 4,643.2 | 464.1 | 13.7 | 8.9 | 100.8 | 8.6 | |
| 1,646.3 | 27,599.9 | 2,762.9 | 509.8 | 22.5 | 21.5 | 54.7 | 11.0 | |
| 1,239.2 | 33,317.5 | 4,410.2 | 554.1 | 15.8 | 14.5 | 59.9 | 8.4 | |
| 716.9 | 28,704.0 | 3,904.6 | 239.4 | 13.3 | 11.1 | 118.9 | 12.8 | |
| 452.2 | 7,188.7 | 829.0 | 161.5 | 24.5 | 30 | 44.1 | 12.3 | |
| 1,302.8 | 13,438.3 | 814.2 | 173.0 | 30.1 | 19 | 77.7 | 14.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Sticking with experts during uncertainty
4 min read•By Rajan Gulati
About Metropolis Health
Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology,... as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India. Read more
-
Incorporated
2000
-
Chairman
Ameera Shah
-
Managing Director
--
-
Group
Metropolis
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Metropolis Healthcare Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Metropolis Health
What is the current share price of Metropolis Healthcare Ltd Today?
The share price of Metropolis Healthcare Ltd is ₹507.40 (NSE) and ₹507.75 (BSE) as of 18-May-2026 IST. Metropolis Healthcare Ltd has given a return of 16.11% in the last 3 years.
What is the current PB & PE ratio of Metropolis Healthcare Ltd?
The P/E ratio of Metropolis Healthcare Ltd is 55.40 times as on 18-May-2026, a 1 premium to its peers’ median range of 54.67 times.
The P/B ratio of Metropolis Healthcare Ltd is 6.96 times as on 18-May-2026, a 17 discount to its peers’ median range of 8.40 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
55.84
|
6.12
|
|
2024
|
69.19
|
8.13
|
|
2023
|
44.76
|
6.52
|
|
2022
|
48.66
|
11.92
|
|
2021
|
62.57
|
16.41
|
What is the 52 Week High and Low of Metropolis Healthcare Ltd?
The 52-week high and low of Metropolis Healthcare Ltd are Rs 600.00 and Rs 400.40 as of 19-May-2026.
What is the market cap of Metropolis Healthcare Ltd?
Metropolis Healthcare Ltd has a market capitalisation of ₹ 10,527 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Metropolis Healthcare Ltd?
Before investing in Metropolis Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.